Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency

• Κύριοι συγγραφείς: M.B. Ates (Συγγραφέας), S. Karup (Συγγραφέας), S. Ugurlu (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: PAGEPress Publications, 2023-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Deficiency of adenosine deaminase 2 (DADA2) is a recessively inherited autoinflammatory disease characterized by systemic inflammation and immunodeficiency. Infliximab proved to be favorable in the treatment of this condition. This case report is concerned with a DADA2 deficient patient treated with...